| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |